English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51334767    在线人数 :  660
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"feng ming hsu"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 31-40 / 60 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-05-25T02:45:37Z Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma Liu W.-L;Gao M;Tzen K.-Y;Tsai C.-L;Feng-Ming Hsu;Cheng A.-L;Cheng J.C.-H.; Liu W.-L; Gao M; Tzen K.-Y; Tsai C.-L; Feng-Ming Hsu; Cheng A.-L; Cheng J.C.-H.
臺大學術典藏 2020-05-25T02:45:36Z Esophageal cancer Cheng J.C.-H;Feng-Ming Hsu;Wu A.J;Kachnic L.A.; Cheng J.C.-H; Feng-Ming Hsu; Wu A.J; Kachnic L.A.
臺大學術典藏 2020-05-25T02:45:36Z NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNAPKcs inhibitor Yu L; Shang Z.-F; Feng-Ming Hsu; Zhang Z; Tumati V; Lin Y.-F; Chen B.P.C; Saha D.
臺大學術典藏 2020-05-25T02:45:35Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases Chiang Y; Yang J.C.-H; Feng-Ming Hsu; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H.
臺大學術典藏 2020-05-25T02:45:35Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C; Huang T.-C; Lin C.-C; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Feng-Ming Hsu; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H.
臺大學術典藏 2020-05-25T02:45:35Z Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation Feng-Ming Hsu; Cheng J.C.-H; Chang Y.-L; Lee J.-M; Koong A.C; Chuang E.Y.
臺大學術典藏 2020-05-25T02:45:33Z Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma Feng-Ming Hsu; Hou W.-H; Huang C.-Y; Wang C.-C; Tsai C.-L; Tsai Y.-C; Yu H.-J; Pu Y.-S; Cheng J.C.-H.
臺大學術典藏 2020-05-25T02:45:33Z Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer Lu S.-L; Feng-Ming Hsu; Chen K.-Y; Ho C.-C; Yang J.C.-H; Cheng J.C.-H.
臺大學術典藏 2020-05-25T02:45:31Z An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non�Vsmall cell lung cancer Wang L; Wu Y.-L; Lu S; Deng L; Ahn M.-J; Feng-Ming Hsu; Iscoe N; Hossain A; Puri T; Zhang P; Orlando M.
臺大學術典藏 2020-05-25T02:45:30Z Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients Huang Y.-S;Chen J.L.-Y;Feng-Ming Hsu;Huang J.-Y;Ko W.-C;Chen Y.-C;Jaw F.-S;Yen R.-F;Chang Y.-C.; Huang Y.-S; Chen J.L.-Y; Feng-Ming Hsu; Huang J.-Y; Ko W.-C; Chen Y.-C; Jaw F.-S; Yen R.-F; Chang Y.-C.

显示项目 31-40 / 60 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目